One sign of the financial turmoil associated with the market for genetic tests is the news that all seven independent directors of 23andMe’s board resigned at the same time on Sept. 18. The reason given was that these directors opposed the plan of CEO and co-founder Anne Wojcicki to take the company private. The once …
September 23, 2024, Intelligence: Late-Breaking Lab News Read More »
